Top sponsors and CROs for 2012-2016 clinical trials in Israel

Of the ten largest industry and academic sponsors of 2012–2016 clinical trials with locations in Israel, six were pharmaceutical companies and four were government and academic institutions.

Of the ten largest industry and academic sponsors of 2012–2016 clinical trials with locations in Israel, six were pharmaceutical companies and four were government and academic institutions. Among industry sponsored trials in Israel, Novartis held the first place, followed by Merck and Bayer. These were followed by Roche, AstraZeneca, Abbvie, Eli Lilly, Novo Nordisk, Pfizer, and Bristol-Myers Squibb, as shown in Figure 1.

Figure 1 Top Industry Sponsors for Clinical Trials in Israel by Number of Trials, 2012-2016.

Source: GlobalData, Pharma Intelligence Center, Deal Analytics [Accessed April 26, 2017]

In terms of the ten largest non-industry clinical trial sponsors in Israel, the top three places were taken by the Sheba Medical Center, Rabin Medical Center, and Hadassah Medical Center, in order, followed by the Tel Aviv Sourasky Medical Center, Rambam Healthcare Campus, Meir Medical Center, Hillel Yaffe Medical Center, Shaare Zedek Medical Center, Haemek Medical Center, and Wolfson Medical Center, as shown in Figure 2.

Figure 2: Top Institutional Sponsors for Clinical Trials in Israel, 2012–2016

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData

I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the privacy policy

Source: GlobalData, Pharma Intelligence Center, Deal Analytics [Accessed April 26, 2017]

GlobalData examined the number of trials that were run by sponsors alone compared to those run by sponsors that engaged a CRO. Out of all trials that started in Israel between 2012 and 2016, 19.3% involved a CRO. It is possible the CRO involvement is an underestimation, because identifying trials with CRO involvement is subject to the availability of that information in the public domain.

Out of the top 10 CROs engaged in Israel, the leader was Quintiles with 35 trials. Pharmaceutical Product Development was second, followed by Parexel, Sarah Cannon Research Institute, INC Research, PRA Health Sciences, Medpace, Covance, Pharmaceutical Research Associates, and ICON, as shown in Figure 3.

Figure 3: Top CROs Involved in Clinical Trials in Israel, 2012–2016